文献速递细菌感染、耐药与抗菌药物医院感染防控

链球菌菌血症死亡预测因素与感染病专科会诊的作用:一项回顾性队列研究

Predictors of Mortality of Streptococcal Bacteremia and the Role of Infectious Diseases Consultation: A Retrospective Cohort Study.
PubMed 文献 · Clin Infect Dis · 2024-01-01

在瑞士洛桑大学医院开展回顾性队列研究,纳入2015至2023年成人链球菌菌血症861例,14天死亡率为8%(65例)。Cox多变量回归显示,Charlson合并症指数>4、化脓性链球菌、脓毒症、下呼吸道感染及有指征但48小时内未行感染源控制与14天死亡相关;48小时内感染病专科会诊和适当抗菌治疗与结局改善相关。

要点

  • 14天死亡率为8%(65例),最常见感染源为心内膜炎(164例,19%)。
  • 48小时内感染病专科会诊(HR 0.29)与适当抗菌治疗(HR 0.28)与结局改善相关。
  • 有指征但48小时内未行感染源控制者14天死亡风险升高(HR 2.62)。

核心结论

  • 研究结果强调感染病专科会诊在指导链球菌菌血症患者抗菌治疗和推荐感染源控制干预中的关键作用。

研究设计与样本

  • 回顾性研究,在瑞士洛桑大学医院开展,纳入2015至2023年成人链球菌菌血症发作,共861例。

主要发现

  • 14天总死亡率为8%(65例)。
  • Mitis组348例(40%),化脓组215例(25%),心内膜炎为最常见感染源(164例,19%)。
  • Charlson合并症指数>4(P .001;HR 2.87;CI 1.58-5.22)、化脓性链球菌(P = .011;HR 2.54;CI 1.24-5.21)、脓毒症(P < .001;HR 7.48;CI 3.86-14.47)、下呼吸道感染(P = .002;HR 2.62;CI 1.42-4.81)及有指征但48小时内未行感染源控制(P = .002;HR 2.62;CI 1.43-4.80)与14天死亡相关。
  • 菌血症起病48小时内实施的干预,如感染病专科会诊(P < .001;HR 0.29;CI .17-.48)和适当抗菌治疗(P < .001;HR .28;CI .14-.57),与结局改善相关。

关键数值与推荐

  • Charlson合并症指数>4:P .001;HR 2.87;CI 1.58-5.22。
  • 化脓性链球菌:P = .011;HR 2.54;CI 1.24-5.21。
  • 脓毒症:P < .001;HR 7.48;CI 3.86-14.47。
  • 下呼吸道感染:P = .002;HR 2.62;CI 1.42-4.81。
  • 有指征但48小时内未行感染源控制:P = .002;HR 2.62;CI 1.43-4.80;感染病专科会诊:P < .001;HR 0.29;CI .17-.48;适当抗菌治疗:P < .001;HR .28;CI .14-.57。

临床怎么用

  • 作者认为,感染病专科会诊在指导链球菌菌血症患者抗菌治疗和推荐感染源控制干预中具有关键作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Streptococcal bacteremia is associated with high mortality. Thia study aims to identify predictors of mortality among patients with streptococcal bacteremia. METHODS: This retrospective study was conducted at the Lausanne University Hospital, Switzerland, and included episodes of streptococcal bacteremia among adult patients from 2015 to 2023. RESULTS: During the study period, 861 episodes of streptococcal bacteremia were included. The majority of episodes were categorized in the Mitis group (348 episodes; 40%), followed by the Pyogenic group (215; 25%). Endocarditis was the most common source of bacteremia (164; 19%). The overall 14-day mortality rate was 8% (65 episodes). The results from the Cox multivariable regression model showed that a Charlson comorbidity index >4 (P .001; hazard ratio [HR], 2.87; confidence interval [CI]: 1.58-5.22), Streptococcus pyogenes (P = .011; HR, 2.54;CI: 1.24-5.21), sepsis (P < .001; HR, 7.48; CI: 3.86-14.47), lower respiratory tract infection (P = .002; HR, 2.62; CI: 1.42-4.81), and absence of source control interventions within 48 hours despite being warranted (P = .002; HR, 2.62; CI: 1.43-4.80) were associated with 14-day mortality. Conversely, interventions performed within 48 hours of bacteremia onset, such as infectious diseases consultation (P < .001; HR, 0.29; CI: .17-.48) and appropriate antimicrobial treatment (P < .001; HR, .28; CI: .14-.57), were associated with improved outcome. CONCLUSIONS: Our findings underscore the pivotal role of infectious diseases consultation in guiding antimicrobial treatment and recommending source control interventions for patients with streptococcal bacteremia.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Fourre N, Zimmermann V, Senn L, et al. Predictors of Mortality of Streptococcal Bacteremia and the Role of Infectious Diseases Consultation: A Retrospective Cohort Study. Clin Infect Dis. 2024. PMID: 38525878. doi:10.1093/cid/ciae168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。